Publications by authors named "Adam Turpcu"

Claim this Profile
S
Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.
Arshad M Khanani, David S Boyer, Charles C Wykoff, Carl D Regillo, Brandon G Busbee, Adam Turpcu

EClinicalMedicine· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis.
Szilárd Kiss, Pravin U Dugel, Arshad M Khanani, Michael S Broder, Eunice Chang, Adam Turpcu

Clin Ophthalmol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States.
JaeJin An, Fang Niu, Adam Turpcu, Yamina Rajput, T Craig Cheetham

Ophthalmic Epidemiol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE Trials.
Ivan J Suñer, Neil M Bressler, Rohit Varma, Chantal M Dolan, James Ward, Adam Turpcu

Retina· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Burden of Retinal Venous Occlusion: An Assessment of Fellow Eyes in 1000 Cases.
Gary Brown, Janet Yoo, Melissa Brown, Adam Turpcu, Yamina Rajput

Ophthalmol Retina· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.
Gary C Brown, Melissa M Brown, Heidi B Lieske, Adam Turpcu, Yamina Rajput

Int J Retina Vitreous· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES.
Melissa M Brown, Gary C Brown, Heidi B Lieske, Irwin Tran, Adam Turpcu

Retina· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials.
Neil M Bressler, Rohit Varma, Paul Mitchell, Ivan J Suñer, Chantal Dolan, Adam Turpcu

JAMA Ophthalmol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Commercial Claims-Based Cost Analysis of Diabetic Retinopathy Screening Patterns.
Kathryn Fitch, Thomas Weisman, Tyler Engel, Adam Turpcu, Helen Blumen

Am Health Drug Benefits· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
Gary C Brown, Melissa M Brown, Adam Turpcu, Yamina Rajput

Ophthalmology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Richard A Brook, Nathan L Kleinman, Sunil Patel, Jim E Smeeding, Ian A Beren, Adam Turpcu

Postgrad Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Mark Danese, Chantal M Dolan, Adam Turpcu

Ophthalmology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.
Neil M Bressler, Rohit Varma, Ivan J Suñer, Chantal M Dolan, James Ward, Adam Turpcu

Ophthalmology· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of and risk factors for diabetic macular edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Michelle Gleeson, Mark Danese, Adam Turpcu

JAMA Ophthalmol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments.
Christine Poulos, A Brett Hauber, Juan Marcos González, Adam Turpcu

Arthritis Care Res (Hoboken)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States.
Neil M Bressler, Rohit Varma, Quan V Doan, Michelle Gleeson, Mark Danese, Adam Turpcu

JAMA Ophthalmol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of first-line anti-vascular endothelial growth factor treatment patterns in wet age-related macular degeneration.
Stephen S Johnston, Kathleen Wilson, Alice Huang, David Smith, Helen Varker, Adam Turpcu

Adv Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX Studies.
Martin J Bergman, William Reiss, Carol Chung, Pamela Wong, Adam Turpcu

Autoimmune Dis· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis.
Stephen S Johnston, Adam Turpcu, Nianwen Shi, Robert Fowler, Bong-Chul Chu

Semin Arthritis Rheum· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to aggregate health? Separability and the effect of framing.
Adam Turpcu, Han Bleichrodt, Quang A Le, Jason N Doctor

Med Decis Making· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis